ALNY
Price
$446.23
Change
-$3.35 (-0.75%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
58.51B
27 days until earnings call
BMRN
Price
$53.84
Change
+$1.22 (+2.32%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
10.34B
25 days until earnings call
Interact to see
Advertisement

ALNY vs BMRN

Header iconALNY vs BMRN Comparison
Open Charts ALNY vs BMRNBanner chart's image
Alnylam Pharmaceuticals
Price$446.23
Change-$3.35 (-0.75%)
Volume$9.16K
Capitalization58.51B
BioMarin Pharmaceutical
Price$53.84
Change+$1.22 (+2.32%)
Volume$30.93K
Capitalization10.34B
ALNY vs BMRN Comparison Chart in %
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. BMRN commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Hold and BMRN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ALNY: $449.58 vs. BMRN: $52.62)
Brand notoriety: ALNY and BMRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 57% vs. BMRN: 116%
Market capitalization -- ALNY: $58.51B vs. BMRN: $10.34B
ALNY [@Biotechnology] is valued at $58.51B. BMRN’s [@Biotechnology] market capitalization is $10.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileBMRN’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • BMRN’s FA Score: 0 green, 5 red.
According to our system of comparison, ALNY is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 3 TA indicator(s) are bullish while BMRN’s TA Score has 3 bullish TA indicator(s).

  • ALNY’s TA Score: 3 bullish, 5 bearish.
  • BMRN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALNY is a better buy in the short-term than BMRN.

Price Growth

ALNY (@Biotechnology) experienced а -0.57% price change this week, while BMRN (@Biotechnology) price change was -4.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +9.50%, and the average quarterly price growth was +52.01%.

Reported Earning Dates

ALNY is expected to report earnings on Oct 23, 2025.

BMRN is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($58.5B) has a higher market cap than BMRN($10.3B). ALNY YTD gains are higher at: 91.059 vs. BMRN (-19.945). BMRN has higher annual earnings (EBITDA): 934M vs. ALNY (-170.84M). ALNY has more cash in the bank: 2.86B vs. BMRN (1.43B). BMRN has less debt than ALNY: BMRN (604M) vs ALNY (1.3B). BMRN has higher revenues than ALNY: BMRN (3.06B) vs ALNY (2.46B).
ALNYBMRNALNY / BMRN
Capitalization58.5B10.3B568%
EBITDA-170.84M934M-18%
Gain YTD91.059-19.945-457%
P/E RatioN/A15.88-
Revenue2.46B3.06B80%
Total Cash2.86B1.43B200%
Total Debt1.3B604M215%
FUNDAMENTALS RATINGS
ALNY vs BMRN: Fundamental Ratings
ALNY
BMRN
OUTLOOK RATING
1..100
7955
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
8100
SMR RATING
1..100
10065
PRICE GROWTH RATING
1..100
3982
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
5016

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (51) in the Biotechnology industry is somewhat better than the same rating for ALNY (96). This means that BMRN’s stock grew somewhat faster than ALNY’s over the last 12 months.

ALNY's Profit vs Risk Rating (8) in the Biotechnology industry is significantly better than the same rating for BMRN (100). This means that ALNY’s stock grew significantly faster than BMRN’s over the last 12 months.

BMRN's SMR Rating (65) in the Biotechnology industry is somewhat better than the same rating for ALNY (100). This means that BMRN’s stock grew somewhat faster than ALNY’s over the last 12 months.

ALNY's Price Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for BMRN (82). This means that ALNY’s stock grew somewhat faster than BMRN’s over the last 12 months.

BMRN's P/E Growth Rating (98) in the Biotechnology industry is in the same range as ALNY (100). This means that BMRN’s stock grew similarly to ALNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYBMRN
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 9 days ago
60%
Declines
ODDS (%)
Bearish Trend 12 days ago
64%
Bearish Trend 4 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CNRG82.900.32
+0.39%
SPDR® Kensho Clean Power ETF
AUDJPY97.97N/A
N/A
Australian Dollar - Japan Yen
CNYAUD0.21N/A
N/A
China Yuan - Australian Dollar
GBPAUD2.04N/A
N/A
United Kingdom Pound - Australian Dollar
GWX39.88-0.16
-0.41%
SPDR® S&P® International Small Cap ETF

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-1.92%
IONS - ALNY
45%
Loosely correlated
-1.52%
SGMO - ALNY
42%
Loosely correlated
+12.09%
ARGX - ALNY
40%
Loosely correlated
-2.56%
INSM - ALNY
38%
Loosely correlated
-3.84%
BMRN - ALNY
38%
Loosely correlated
-2.14%
More

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with TECH. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-2.14%
TECH - BMRN
48%
Loosely correlated
-1.44%
IDYA - BMRN
45%
Loosely correlated
+0.08%
BEAM - BMRN
45%
Loosely correlated
-2.12%
NRIX - BMRN
43%
Loosely correlated
-4.25%
IRON - BMRN
43%
Loosely correlated
+0.18%
More